Showing results (271-280 of 369) with videos related to

Sort By:
Pageof 37
Leukemia & Lymphoma|March 26, 2015
Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapyYa-Zhen Qin, Lan-Ping Xu, Huan Chen, et al.
Blood Science (Baltimore, Md.)|September 27, 2024
Pre-transplantation levels of lysine (K)-specific methyltransferase 2A (<i>KMT2A</i>) partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantationDao-Xing Deng, Xiao-Hang Ma, Ze-Hua Wu, et al.
Bone Marrow Transplantation|January 26, 2022
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort studyLi-Ping Yang, Peng Zhao, Ye-Jun Wu, et al.
Autophagy|May 12, 2021
CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progressionXuan Li, Kai-Bin Yang, Wei Chen, et al.
Bone Marrow Transplantation|April 20, 2020
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomesQi Chen, Xin Zhao, Hai-Xia Fu, et al.
Blood|January 22, 2011
Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phaseQian Jiang, Lan-Ping Xu, Dai-Hong Liu, et al.
Annals of Hematology|January 3, 2021
Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaQi Chen, Xiao-Lu Zhu, Xin Zhao, et al.
Frontiers in Oncology|March 15, 2021
Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 StudyYu-Qian Sun, Ting-Ting Han, Yu Wang, et al.
Oncoimmunology|January 27, 2017
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized studyXiang-Yu Zhao, Xiao-Su Zhao, Yu-Tong Wang, et al.
Science Translational Medicine|June 26, 2024
TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancerHai-Liang Zhang, Bing-Xin Hu, Zhi-Peng Ye, et al.
Pageof 37